The Biogen Idec neurology sales force is currently expanding. We’re looking to recruit proven sales achievers with at least three to five years of experience in pharma, specialty, hospital, and/or biotech sales.
It is a testament to our rich pipeline and future prospects that we are expanding our organization in preparation for multiple new product launches.
In this field based, specialty sales representative position you will be called upon to sell our Neurology products, AVONEX® and Tysabri® with key stakeholders in the Multiple Sclerosis community: including Neurologists, allied health professionals, local MS chapters.
The Area Business Manager is responsible for developing plans for their business territory that are executable and focus on getting the greatest benefit to the greatest number of MS patients given available resources. They must also be able to communicate openly with peers, supervisors, and all company employees with the objective of improving the quality of our business and deliver sales results for their territory.
In this role, you will convey complex clinical, and reimbursement information to these groups so that all appropriate patients can benefit from therapy. You must be able to utilize strong interpersonal skills to establish relationships of trust that allow for directed probing to uncover the customer's needs and develop solutions within the Biogen Idec framework that meet these needs. This position works closely with cross functional peers to ensure that the Biogen IDEC suite of services is made available as needed.
Minimum 3-5+ years B2B and/or pharmaceutical/biotech sales experience required
Proven track record of success as demonstrated by consistent high ranking (top 30%) over 3 years (+), awards, etc and able drive results in a difficult market
Documented experience working in a collaborative setting
Customer focused and able to drive for results
Must have the desire and capabilities to help us achieve new levels of success as we look to the future
BS/BA required, MBA a plus.
Biogen (NASDAQ: BIIB) is a global leader in the discovery, development and delivery of innovative therapies to improve the lives of...